John Hussman's HAE Position Overview
John Hussman (via Hussman Strategic Advisors, Inc.) currently holds 10,500 shares of Haemonetics Corporation (HAE) worth $591,780, representing 0.13% of the portfolio. First purchased in 2025-Q3, this short-term holding has been held for 3 quarters.
Based on 13F filings, John Hussman has maintained this position in HAE for several quarters, showing initial confidence in the investment. Largest addition occurred in Q1 2026, adding 10,500 shares. Largest reduction occurred in Q4 2025, reducing 10,500 shares.
Analysis based on 13F filings available since 2013 Q2
John Hussman's Haemonetics Corporation (HAE) Holding Value Over Time
Track share changes against reported price movement
Quarterly Haemonetics Corporation (HAE) Trades by John Hussman
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +10,500 | New Buy | 10,500 | $56.36 |
| Q4 2025 | -10,500 | Sold Out | 0 | $0.00 |
| Q3 2025 | +10,500 | New Buy | 10,500 | $48.74 |
John Hussman's Haemonetics Corporation Investment FAQs
John Hussman first purchased Haemonetics Corporation (HAE) in Q3 2025, acquiring 10,500 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
John Hussman has held Haemonetics Corporation (HAE) for 3 quarters since Q3 2025.
John Hussman's largest addition to Haemonetics Corporation (HAE) was in Q3 2025, adding 10,500 shares worth $511,770.
According to the latest 13F filing for Q1 2026, John Hussman's firm, Hussman Strategic Advisors, Inc., owns 10,500 shares of Haemonetics Corporation (HAE), valued at approximately $591,780.
As of the Q1 2026 filing, Haemonetics Corporation (HAE) represents approximately 0.13% of John Hussman's publicly disclosed stock portfolio, making it one of their key holdings.
John Hussman's peak holding in Haemonetics Corporation (HAE) was 10,500 shares, as reported at the end of Q3 2025.